Company Directory > CRO > IMS Consulting Group
IMS Consulting Group was the management consulting arm of IMS Health, a major provider of information, services, and technology for the healthcare industry. The group specialized in providing strategic advice to pharmaceutical, biotech, and life sciences companies on critical business issues such as portfolio strategy, launch strategy, pricing, and market access. Following the merger of IMS Health and Quintiles in 2016 to form IQVIA, the consulting services were integrated into the broader IQVIA consulting offerings. The domain imscg.com remains registered to IQVIA, reflecting its historical role as a specialized consulting division.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Management Consulting
SIZE & FINANCIALS
Ownership:subsidiary
Status:acquired
STOCK
Exchange:NYSE
Ticker:IQV
0
CORPORATE STRUCTURE
Parent Company:IQVIA
Acquired By:IQVIA (via merger of IMS Health and Quintiles) (2016-10-01)
COMPETITION
Position:Leader
Competitors:McKinsey & Company, Boston Consulting Group, Bain & Company, ZS Associates
LINKS
Website:imscg.com
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IMS Consulting Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IMS Consulting Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.